Anita Esquerra-Zwiers

Dr. Anita Esquerra-Zwiers


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in The Journal of Pediatrics
Verified
Journal Article
Closed access
PMPaula Meier
Paula Meier
APAloka L. Patel
Aloka L. Patel
AEAnita Esquerra-Zwiers
Anita Esquerra-Zwiers

20 November 2015 in Journal of Human Lactation
Verified
Journal Article
Open access
PDF file
AEAnita Esquerra-Zwiers
Anita Esquerra-Zwiers
BRBeverly Rossman
Beverly Rossman
PMPaula Meier
Paula Meier
JEJanet Engstrom
Janet Engstrom
JJJudy Janes
Judy Janes
APAloka L. Patel
Aloka L. Patel
Background: Pasteurized donor human milk (DHM), rather than preterm infant formula, is recommended for premature infants when mother’s milk is not available. Objective: This study explored the maternal decision-making process in providing consent for DHM feedings. Methods: In-depth semistructured interviews were conducted with 20 mothers of premature (mean gestational age = 27 weeks, birth weight = 942 grams) infants hospitalized in the neonatal intensive care unit (NICU) in this qualitative, descriptive study. Conventional content analysis was used to analyze the data. Results: Although only 1 mother had any previous knowledge of DHM, all mothers provided consent for DHM because they “wanted what is best for my baby.” Mothers trusted that DHM was better than formula when their infant’s feeding requirements exceeded their own milk supply. However, most mothers described a tension between wanting their infants to receive only “their” milk and DHM being “somebody else’s milk.” This desire to be the only provider of human milk was more common than concerns about the quality and safety of DHM. The mothers’ tension was mediated by trusting the NICU clinicians’ recommendations, having adequate time to make an informed decision, observing the positive outcomes of DHM, and feeling empowered that they made the best decision for their infant. Conclusion: The experiences of these mothers reflect the importance of approaching mothers for consent only when DHM is needed, respecting mothers’ beliefs and values about DHM, and providing help in mediating any tension with regard to their infants receiving “somebody else’s milk.”

1 January 2022 in Breastfeeding Medicine
Verified
Journal Article
Closed access
AEAnita Esquerra-Zwiers
Anita Esquerra-Zwiers
AVAlexandra Vroom
Alexandra Vroom
DGDonna Geddes
Donna Geddes
CLChing Tat Lai
Ching Tat Lai
Objective: Human milk (HM) sodium (Na) and potassium (K) concentrations, as well as the Na and K ratio (Na:K), are associated with stages of lactation and breast health. Portable point-of-care instruments to measure HM biomarkers related to secretory activation or tight junction disturbances would supply clinicians immediate information for individualized lactation care. This study compared HM concentrations of Na and K and Na:K measured by a biochemist with inductively coupled plasma optical emission spectrometry (ICP-OES) and measured by a clinician with ion-selective electrode probes (ISEPs). Design: HM samples (n = 92) were participant collected and donated on day 10 postpartum through a convenience sample of breastfeeding women in West Michigan. Na and K concentrations were determined using ICP-OES and ISEPs. Bland–Altman plots, paired sample t-test, and logistic regressions were completed using R 3.4.4 and R Studio 1.2.1335 with package Lattice. Results: Na concentrations were not significantly different with ICP-OES (13.0 ± 14.8 mM) and ISEPs (12.6 ± 13.7 mM, p = 0.06), whereas K concentrations (ICP-OES 16.1 ± 1.9 mM, ISEPs 14.4 ± 2.4 mM, p < 0.001) and Na:K (ICP-OES 0.81 ± 0.92, ISEPs 1.01 ± 1.62, p = 0.011) were significantly different. Between both methods, the Na, K, and Na: K linear relationships were statistically significant. Conclusion: With additional longitudinal and clinical usefulness research clinicians could use ISEPs to collect and interpret relevant lactation data to support individualized lactation interventions.

22 January 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
RHRebecca Hoban
Rebecca Hoban
MSMichael Schoeny
Michael Schoeny
AEAnita Esquerra-Zwiers
Anita Esquerra-Zwiers
TKTanyaporn K. Kaenkumchorn
Tanyaporn K. Kaenkumchorn
GCGina Casini
Gina Casini
APAloka L. Patel
Aloka L. Patel
Mother’s own milk (MOM) reduces the risk of morbidities in very low birth weight (VLBW) infants. When MOM is unavailable, donor breastmilk (DM) is used, with unclear impact on short- and long-term growth. This retrospective analysis compared anthropometric data at six time points from birth to 20–24 months corrected age in VLBW infants who received MOM supplements of preterm formula (n = 160) versus fortified DM (n = 161) during neonatal intensive care unit (NICU) hospitalization. The cohort was 46% female; mean birth weight and gestational age (GA) were 998 g and 27.3 weeks. Multilevel linear growth models assessed changes in growth z-scores short-term (to NICU discharge) and long-term (post-discharge), controlling for amount of DM or formula received in first 28 days of life, NICU length of stay (LOS), birth GA, and sex. Z-scores for weight and length decreased during hospitalization but increased for all parameters including head circumference post-discharge. Short-term growth was positively associated with LOS and birth GA. A higher preterm formula proportion, but not DM proportion, was associated with slower rates of decline in short-term growth trajectories, but feeding type was unrelated to long-term growth. In conclusion, controlling for total human milk fed, DM did not affect short- or long-term growth.

1 January 2021 in Breastfeeding Medicine
Verified
Journal Article
Closed access
AEAnita Esquerra-Zwiers
Anita Esquerra-Zwiers
MSMichael E. Schoeny
Michael E. Schoeny
JEJanet Engstrom
Janet Engstrom
JWJennifer Wicks
Jennifer Wicks
JSJennifer Szotek
Jennifer Szotek
APAloka L. Patel
Aloka L. Patel
Objective: To compare (1) differences in mother's own milk (MOM) provision and enteral feeding outcomes, (2) differences in preterm formula and donor human milk (DHM) uses as bridges to exclusive MOM feedings at discharge, and (3) MOM and enteral feeding outcomes for racial/ethnic subgroups before and after the implementation of a hospital DHM feeding program. Methods: Retrospective data from 313 very low birth weight (VLBW; birth weight <1,500 g) infants born between January 2011 to December 2012 (pre-DHM, n = 157) and April 2013 to March 2015 (DHM, n = 156) were analyzed. Results: For this predominantly low-income and minority VLBW infant cohort, the percent of enteral fed hospitalization days was higher in the DHM group (pre-DHM 94% [88, 97] versus DHM 98% [95, 99], p < 0.001). Although MOM remained the predominant first enteral feeding type, significantly fewer DHM infants received MOM (pre-DHM 89% versus DHM 75%, p = 0.001). During days of life 1–14, a lower percentage of DHM infants received 100% MOM (pre-DHM 68% versus DHM 55%, p = 0.02). For the entire cohort, the risk for MOM discontinuation was significantly associated with maternal young age, multiparity, non-Hispanic Black race/ethnicity, and low income. Implementation of a DHM program did not predict duration of MOM feedings. However, non-Hispanic White infants had a longer duration of MOM feedings with DHM availability. Conclusions: Our findings highlight the importance of using precise dose and exposure period methodology to determine the impact of DHM on MOM provision. In addition, DHM availability may be associated with varying effects on MOM provision among racial/ethnic groups.

5 October 2022 in The Journal of Pediatrics
Verified
Journal Article
Closed access
AEAnita Esquerra-Zwiers
Anita Esquerra-Zwiers
CMCarly Mulder
Carly Mulder
LCLauren Czmer
Lauren Czmer
APAnastasia Perecki
Anastasia Perecki
EGEmilie Dykstra Goris
Emilie Dykstra Goris
DGDonna Geddes
Donna Geddes